Pharmacological causes of hyperprolactinemia

References

• AcienPMauriMGutierrezMClinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenismHum Rep1997124239
   PubMed Web of Science ®Google Scholar
• AmsterdamJDGarcia-EspanaFGoodmanDBreast enlargement during chronic antidepressant therapyJ Affect Disord19974615169479619
   PubMed Web of Science ®Google Scholar
• AguilarELopezFPinillaLEffects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female ratsRev Esp Fisiol19854118364041067
   PubMedGoogle Scholar
• AndersonIMCowenPJClomipramine enhances prolactin and growth hormone responses to L-tryptophanPsychopharmacology19868913133016787
   PubMed Web of Science ®Google Scholar
• AntorRFSexauerJDRandallCLAmoxapine elevates serum prolactin in depressed menJ Affect Disord19835305106229562
   PubMed Web of Science ®Google Scholar
• ApiquianRFresarAUlloaREAmoxapine as an atypical antipsychotic: a comparative study versus risperidoneNeuropsychopharmacology20053022364415956984
   PubMed Web of Science ®Google Scholar
• AshPRBoumaDExaggerated hyperprolactinemia in response to thiothixeneArch Neurol19813853457247797
   PubMedGoogle Scholar
• AtmacaMKulogluMTezcanEQuetiapine is not associated with increase in prolactin secretion in contrast to haloperidolArch Med Res200233562512505103
   PubMed Web of Science ®Google Scholar
• BarbieriCLarovereMTMariottiGProlactin stimulation by intravenous labetalol is mediated inside CNSClin Endocrinol (Oxf)198216615197105431
   PubMed Web of Science ®Google Scholar
• BartGBorgLSchlugerJHSuppressed prolactin response to dynorphin A1-3 in methadone-maintained versus control subjectsJ Pharmacol Exp Ther2003306581712730354
   PubMed Web of Science ®Google Scholar
• BasturkMKaraaslanFEselEEffects of short and long term lithium treatment on serum prolactin levels in patients with bipolar affective disorderProg Neuropsychopharmacol Biol Psychiatry2001253152211294478
   PubMed Web of Science ®Google Scholar
• BaumgartnerAGrafKJKurtenIProlactin in patients with major depressive disorder and in healthy subjects. II. Longitudinal study of basal prolactin and post-TRH-stimulated prolactin levelsBiol Psychiatry198824268853135848
   PubMed Web of Science ®Google Scholar
• BenkerGJaspersCHauslerGControl of prolactin secretionKlin Wochenschr1990681157672126309
   PubMedGoogle Scholar
• BliesenerNYokusogluHQuednowBBUsefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case reportPharmacopsychiatry2004371899115467977
   PubMed Web of Science ®Google Scholar
• BonuccelliUMurialdoGMartinoEEffects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjectsClin Neuropharmacol19858165743924400
   PubMed Web of Science ®Google Scholar
• BressanRAErlandssonKSpencerEPProlactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patientsPsychopharmachology(Berl)200417536773
   PubMed Web of Science ®Google Scholar
• BrowersJRAssiesJWiersingaWMPlasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: a cross-over study in healthy volounteersClin Endocrinol (Oxf)198012435407428183
   PubMed Web of Science ®Google Scholar
• Bruins SlotLADe VriesLNewman-TancrediADifferential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinaseEur J Pharmacol2006534637016497294
   PubMed Web of Science ®Google Scholar
• BuckleyPFAripipazole: efficacy and tolerability profile of a novel acting atypical antipsychoticDrugs Today (Barc)2003391455112698209
   PubMed Web of Science ®Google Scholar
• BunkerMTMarkenPASchneiderhanMEAttenuation of antipsychotic-induced hyperprolactinemia with clozapineJ Child Adolesc Psychopharmacol199776599192542
   PubMed Web of Science ®Google Scholar
• BuschDAFangVSMeltzerHYSerum prolactin levels following intramuscolar chlorpromazine: two and three-hours response as predictors of six-hour responsePsychiatry Res19791153945130
   PubMed Web of Science ®Google Scholar
• CanusoMCHanauMJhambKKOlanzapine use in women with antipsychotic-induced hyperprolactinemiaAm J Psychiatry199815514589766782
   PubMed Web of Science ®Google Scholar
• CassanoGBFagioliniALattanziLAripiprazole in the Treatment of Schizophrenia: A Consensus Report produced by Schizophrenia Experts in ItalyClin Drug Invest200727113
   PubMed Web of Science ®Google Scholar
• CavallaroRCocchiFAngeloneSMCabergoline treatment of risperidone-induced hyperprolactinemia: a pilot studyJ Clin Psychiatry2004651879015003071
   PubMed Web of Science ®Google Scholar
• CohenIGBiedermanJTreatment of risperidone-induced hyperprolactinemia with a dopamine agonist in childrenJ Child Adolesc Psychopharmacol2001114354011838826
   PubMed Web of Science ®Google Scholar
• CohenMADaviesPHDrug therapy and hyperprolactinemiaAdv Drug Reaction Bull19981907236
   Google Scholar
• ConstineLSRubinPWoolfPDHyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignanciesJ Clin Oncol198751841513681371
   PubMed Web of Science ®Google Scholar
• CooperDSGelenbergAJWojcikJCThe effect of amoxapine and imipramine on serum prolactin levelsArch Intern Med1981141102357018438
   PubMedGoogle Scholar
• CosiCCarilla-DurandEAssieMBPartial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at D2 receptors: G protein activation and prolactin releaseEur J Pharmacol20065351354416554049
   PubMed Web of Science ®Google Scholar
• CowenPJSargentPAChanges in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5HT neurotransmissionJ Psychopharmacol19971134589443523
   PubMed Web of Science ®Google Scholar
• CrawfordAMBeasleyCMJrTollefsonGDThe acute and long term affect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsSchizophr Res19972641549376336
   PubMed Web of Science ®Google Scholar
• CrowleyTJHydinger-MacdonaldMMotility, parkinsonism, and prolactin with thiothixene and thioridazineArch Gen Psychiatry198138668757247630
   PubMed Web of Science ®Google Scholar
• DavidSRTaylorCCKinonBJThe effects of olanzapin, risperidone and haloperidol on plasma prolactin levels in patients with schizophreniaClin Ther20002210859611048906
   PubMed Web of Science ®Google Scholar
• DavisJRSelbyCJeffcoateWJOral contraceptive agents do not affect serum prolactin in normal womenClin Endocrinol (Oxf)198420427346609028
   PubMed Web of Science ®Google Scholar
• DelvaNJBrooksDLFranklinMEffects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjectsJ Psychiatry Neurosci2002274293712491576
   PubMed Web of Science ®Google Scholar
• De LeoVLanzettaDVanniALLow estrogen oral contraceptives and the hypothalamo-pituitary axisContraception199144155611832628
   PubMed Web of Science ®Google Scholar
• Di RenzoGAmorosoSTagliatelaMPharmacological characterization of serotonin receptors involved in the control of prolactin secretionEur J Pharmacol198916237132524399
   PubMed Web of Science ®Google Scholar
• DorevitchAAronzonRStarkMPsychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemiaActa Obstet Gynecol Scand19917037561746267
   PubMed Web of Science ®Google Scholar
• EmilianoABFFudgeJLFrom galactorrhea to osteopenia, Rethinking serotonin-prolactin interactionsNeuropsychopharmacology2004298334614997175
   PubMed Web of Science ®Google Scholar
• FairleyKFBarrieJUJohnsonWSterility and testicular atrophy related to cyclophosphamide therapyLancet1972156894110052
   PubMed Web of Science ®Google Scholar
• FoleyKFKastREReview of evidence that posttransplantation psychiatric treatment commonly affects prolactin levels and thereby influences graft fateGen Hosp Psychiatry200628230316675366
   PubMed Web of Science ®Google Scholar
• FothDRomerTProlactin serum levels in postmenopausal women receiving long-term hormone replacement therapyGynecol Obstet Invest4412469286727
   PubMed Web of Science ®Google Scholar
• FowlieSBurtonJHyperprolactinaemia and nonpuerperal lactation associated with clomipramineScott Med J198732523602989
   PubMed Web of Science ®Google Scholar
• FrantzAGProlactinN Engl J Med1978298201339087
   PubMed Web of Science ®Google Scholar
• FreemanMEKanyicskaBLerantAProlactin : structure, function and regulation of secretionPhysiol Rev200080152363111015620
   PubMed Web of Science ®Google Scholar
• FricMLauxGPlasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neurolepticsPsychiatric Prax200330Suppl 2S97101
   PubMedGoogle Scholar
• FryePEPariserSFKimMHBromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophreniaJ Clin Psychiatr1982432523
   PubMed Web of Science ®Google Scholar
• FujinoTKatoHYamashitaSEffects of domperidone on serum prolactin levels in human beingsS Endocrinol Jpn1980275215
   PubMedGoogle Scholar
• GibneyJSmithTPMc KennaTJThe impact on clinical practice of routine screening for macroprolactinemiaJ Clin Endocrinol Metab20059039273215811931
   PubMed Web of Science ®Google Scholar
• GoffDCPoseverTHerzLAn exploratory haloperidol-controlled dose finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disordersJ Clin Phychopharmacol199818296304
   PubMed Web of Science ®Google Scholar
• GoldMSRedmondDEJrDonabedianRKIncrease in serum prolactin by endogenous and esogenous opiates. Evidence for antidopamine and antipsychotic effectAm J Psychiatry197813514151630292
   PubMed Web of Science ®Google Scholar
• GoldsteinJMQuetiapine fumarate: a new atypical antipsychoticDrugs Today (Barc)19993519321012973385
   PubMed Web of Science ®Google Scholar
• GoldsteinSRSelective estrogen receptor modulators: a new category of compounds to extend postmenopausal women’s healthInt J Fertil Womens Med199944221610569450
   PubMedGoogle Scholar
• GoodnickPJRodriguezLSantanaOAntispychotics: impact on prolactin levelsExpert Opin Pharmacother2002313819112387684
   PubMedGoogle Scholar
• GoyotGDebrayQHugRMeasurement of basal plasma levels of three anterior pituitary hormones during acute or chronic treatment with tricyclic antidepressantsEncephale19851145514017937
   PubMedGoogle Scholar
• GreenAIBrownWAProlactin and neuroleptic drugsEndocrinol Metab Clin North Am198817213232897910
   PubMed Web of Science ®Google Scholar
• GruenPGSacharEJAltmanNRelation of plasma prolactin to clinical response in schizophrenic patientsArch Gen Psychiatry1978351222729592
   PubMed Web of Science ®Google Scholar
• HaddadPMWieckAAntidepressant-induced hyperprolactinaemiaJ Psychopharmacol200014Suppl 3A28
   Google Scholar
• HaddadPMWieckAAntipsychotic induced hyperprolactinemia: mechanisms, clinical features and managementDrugs200464229131415456328
   PubMed Web of Science ®Google Scholar
• HalbreichUKahnLSHyperprolactinemia and schizophrenia: mechanisms and clinical aspectsJ Psychiatr Pract200393445315985953
   PubMedGoogle Scholar
• HalbreichUKinonBJGilmoreJAElevated prolactin level in patients with schizophreniaMechanisms and related adverse effects Psychoneuroendocrinology200328Suppl 15367
   PubMed Web of Science ®Google Scholar
• HamnerMBArvanitisLAMillerBGPlasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204, 636)Psychopharmacol Bull199632107108927658
   PubMed Web of Science ®Google Scholar
• Hinterberger-FischerMOgrisEKierPElevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancerAm J Clin Oncol200023325910955855
   PubMed Web of Science ®Google Scholar
• HutchinsonJMurphyMHarriesRGalactorrhoea and hyperprolactinemia associated with Protease InhibitorsLancet20003561003411041407
   PubMed Web of Science ®Google Scholar
• HwangPLNgCSCheongSTEffect of oral contraceptives on serum prolactin: a longitudinal study in 126 normal premenopausal womenEndocrinol (Oxf)19862412733
   Web of Science ®Google Scholar
• JarvinenARagoLMannistoPTEffects of central and peripheral type benzodiazepine ligands on thyrotropin and prolactin secretionNeuropeptides199221183911321364
   PubMed Web of Science ®Google Scholar
• KaneJMLeuchtSCarpenterDExpert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summaryJ Clin Psychiatry200364Suppl 1251914640142
   PubMed Web of Science ®Google Scholar
• KapurSZipurskyRJonesCA positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancyArch Gen Psychiatry200057553910839333
   PubMed Web of Science ®Google Scholar
• KapurSZipurskyRBRemingtonG5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigationAm J Psychiatry199815592189659858
   PubMed Web of Science ®Google Scholar
• KauppilaMKoskinenPIrjalaKLong-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adultsBone Marr Transplant1998a223317
   PubMed Web of Science ®Google Scholar
• KauppilaMViikariJIrjalaKThe hypothalamus-pituitary-gonad axis and testicular function in male patients after treatment for haematological malignanciesJ Intern Med1998b244411169845857
   PubMed Web of Science ®Google Scholar
• KearnsAEGoffDCHaydenDLRisperidone-associated hyperprolactinemiaEndocr Pract20006425911155212
   PubMedGoogle Scholar
• KelestimurFSahinYComparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutismFertil Steril1998696699457935
   PubMed Web of Science ®Google Scholar
• KellerRMonginiFSwitch to quetiapine in antipsychotic agent-related hyperprolactinemiaNeurol Sci200223233512522680
   PubMed Web of Science ®Google Scholar
• KelleySRKamalTJMolitchMEMechanism of verapamil calcium channel blockade-induced hyperprolactinemiaAm J Physiol19962701 Pt1E961008772480
   PubMed Web of Science ®Google Scholar
• KimKSPaeCUChaeJHEffects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidoneJ Clin Psychiatry2002634081312019665
   PubMed Web of Science ®Google Scholar
• KinonBJAhlJLiu-SeifertHImprovement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotic or risperidone to olanzapinePsychoneuroendocrinology2006315778816488084
   PubMed Web of Science ®Google Scholar
• KinonBJBassonBRGilmoreJAStrategies for switching from conventional antipsychotic drugs or risperidone to olanzapineJ Clin Psychiatry2000618334011105736
   PubMed Web of Science ®Google Scholar
• KinonBJGilmoreJALiuHPrevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidonePsychoneuroendocrinology2003a28Suppl 2556812650681
   PubMed Web of Science ®Google Scholar
• KinonBJGilmoreJALiuHHyperprolactinemia in response to antipsychotic drugs; characterization across comparative clinical trialsPsychoneuroendocrinology2003b28Suppl 2S6982
   PubMed Web of Science ®Google Scholar
• KinonBJStaufferVLMcGuireHCThe effects of antipsychotic drug treatment on prolactin concentrations in elderly patientsJ Am Med Dir Assoc2003c41899412837139
   PubMedGoogle Scholar
• KleinbergDLDavisJMde CosterRProlactin levels and adverse events in patients treated with risperidoneJ Clin Psychopharmacol19991957619934944
   PubMed Web of Science ®Google Scholar
• KniggeUPHistaminergic regulation of prolactin secretionDan Med Bull199037109242188799
   PubMed Web of Science ®Google Scholar
• KniggeUMatzenSWarbergJEffects of H2-receptor antagonists on prolactin secretion: specificity and mediation of the responseActa Endocrinol (Copenh)198711546182888250
   PubMedGoogle Scholar
• KolakowskaTWilesDHGelderMGClinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazines treatmentPsychopharmacology (Berl)19764910178814
   PubMed Web of Science ®Google Scholar
• KopecekMBaresMSvarcJHyperprolactinemia after low dose of amisulprideNeuro Endocrinol Lett2004254192215665803
   PubMed Web of Science ®Google Scholar
• KuhnKUMeyerKMaierWFlupenthixole—a partial atypical neurolepticFortschr Neurol Psychiatr200068Suppl 1S384110907612
   PubMed Web of Science ®Google Scholar
• KunwarARMegnaJLResolution of risperidone-induced hyperprolactinemia with substitution of quetiapineAnn Pharmacother200337206812549948
   PubMed Web of Science ®Google Scholar
• LaakmannGSchuleCBaghaiTEffects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjectsPsychoneuroendocrinology1999247698410451911
   PubMed Web of Science ®Google Scholar
• LafuenteAMarcoJEsquifinoAIOpioids and the pulsatile prolactin secretory pattern: effects of hyperprolactinemiaVet Hum Toxicol19943652487900271
   PubMedGoogle Scholar
• LaineKAnttilaMHeinonenELack of adverse interactions between concomitantly administered selegiline and citalopramClin Neuropharmacol199720419339331518
   PubMed Web of Science ®Google Scholar
• LambertsSWvan KoetsvelPMHoflandLJThe effect of clozapine on prolactin secretion at the level of the lactotrophLife Sci1990461013192325501
   PubMed Web of Science ®Google Scholar
• LeeBHKimYKParkSHUsing aripiprazole to resolve antipsychotic induced symptomatic hyperprolactinemia: a pilot studyProg Neuropsychopharmacol Biol Psychiatry2006307141716571367
   PubMed Web of Science ®Google Scholar
• LeePAKellyMRWallinJDIncreased prolactin levels during reserpine treatmemt of hypertensive patientsJAMA1976235231617131202
   PubMed Web of Science ®Google Scholar
• LeuchtSPitschel-WalzGEngelRRAmisulpride, an Unusual “Atypical” Antipsychotic: A Meta- Analysis of Randomized Controlled TrialsAm J Psychiatry20021591809011823257
   PubMed Web of Science ®Google Scholar
• Levi-MinziSBermanzohnPCSirisSGBromocriptine for “negative” schizophreniaCompr Psychiatry199132210161679383
   PubMed Web of Science ®Google Scholar
• LiebermanJADopamine partial agonists: a new class of antipsychoticsCNS Drugs2004182516715015905
   PubMed Web of Science ®Google Scholar
• LucianoAAShermanBMChaplerFKHyperprolactinemia and contraception: a prospective studyObstet Gynecol198565506103982724
   PubMed Web of Science ®Google Scholar
• Mc CallumRWSowersJRHershmanJMMetoclopramide stimulates prolactin secretion in manJ endocrinol Metab197642114852
   Web of Science ®Google Scholar
• McKeageKPloskerGLAmisulpride: a review of its use in the management of schizophreniaCNS drugs2004189335615521794
   PubMed Web of Science ®Google Scholar
• ManciniAMGuitelmanAVargasCAEffect of sulpiride on serum prolactin levels in humansJ Clin Endocrinol Metab19764218141249187
   PubMed Web of Science ®Google Scholar
• MannistoPTKorttilaKSeppalaTSerum prolactin after a single and subchronic oral administration of chlorpromazine and sulpiride. A cross over study in healthy volunteersArzneimittelforschung1978287681580204
   PubMed Web of Science ®Google Scholar
• MarkenPAHaykalRFFisherJNManagement of psychotropic-induced hyperprolactinemiaClin Pharm19921185161341991
   PubMedGoogle Scholar
• MarkianosMHatzimanolisJLycourasLProlactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapineSchizophr Res200256111712084414
   PubMed Web of Science ®Google Scholar
• MaskallDDZisAPLamRWProlactin response to buspirone challenge in the presence of dopaminergic blockadeBiol Psychiatry19953823598547445
   PubMed Web of Science ®Google Scholar
• MatsuokaINakaiTMiyakeMEffects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotenceJpn J Psychiatry Neurol198640639462885437
   PubMedGoogle Scholar
• Mc CanceSLCohenPRCowenPJLithium increases 5-HT-mediated prolactin releasePsychopharmacology (Berl)198999276812508166
   PubMed Web of Science ®Google Scholar
• MelkerssonKDifferences in prolactin elevation and related symptoms of atypical antipsychotic in schizophrenic patientsJ Clin Psychiatry200566761715960571
   PubMed Web of Science ®Google Scholar
• MeltzerHBastaniBJayathilateKFluoxetine, but not tricyclics antidepressants, potentiates the 5hydroxytryptophan-mediated increase in plasma cotisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorderNeuropsychopharmacology1997171119194044
   PubMed Web of Science ®Google Scholar
• MeltzerHYBuschDAFangVSSerum neuroleptic and prolactin levels in schizophrenic patients and clinical responsePsychiatry Res19839271836580660
   PubMed Web of Science ®Google Scholar
• MeltzerHYFangVSThe effect of neuroleptic on serum prolactin in schizophrenic patientsArch Gen Psychiatry197633279861259521
   PubMed Web of Science ®Google Scholar
• MeltzerHJFangVSTricouBJEffect of antidepressants on neuroendocrine axis in humansAdv Biochem Psychopharmacol198232303166124090
   PubMedGoogle Scholar
• MeltzerHYGudelskyGADA and SE effects of clozapine. Implication for a unique clinical profileArzeimittelforschung19924226872
   PubMed Web of Science ®Google Scholar
• MeltzerHYMaesMEffects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjectsBiol Psychiatry199435316238011800
   PubMed Web of Science ®Google Scholar
• MillerKKManagement of hyperprolactinemia in patients receiving antipsychoticsCNS Spectr20049Suppl 7283215303078
   PubMed Web of Science ®Google Scholar
• MolitchMEPathologic hyperprolactinemiaEndocrinol Metab Clin North Am1992218779011486880
   PubMed Web of Science ®Google Scholar
• MolitchMEMedication-induced hyperprolactinemiaMayo Clin Proc2005801050716092584
   PubMed Web of Science ®Google Scholar
• MonteleonePZontiniGSteardoLFailure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophreniaPsychoneuroendocrinology198510475803003777
   PubMed Web of Science ®Google Scholar
• MontgomeryJWinterbottomEJessaniMPrevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatmentJ Clin Psychiatry2004651491815554761
   PubMed Web of Science ®Google Scholar
• MorosiniPPCampanellaNGhirelliSCimetidine and hyperprolactinemiaBoll Soc Ital Biol Sper1979551417551779
   PubMedGoogle Scholar
• MuderrisIIBayramFClinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutismJ Endocrinol Invest199922165810219882
   PubMed Web of Science ®Google Scholar
• MullerEELocatelliVCellaSProlactin lowering and-releasing drugs. Mechanisms of action and therapeutic applicationsDrugs1983253994326133737
   PubMed Web of Science ®Google Scholar
• NewmanMEShapiraBLererBEvaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical reviewInt J Neuropsychopharmacol19981496911281946
   PubMed Web of Science ®Google Scholar
• NielsenJLPlasma prolactin during treatment with nortriptylineNeuropsychobiology198065257366815
   PubMed Web of Science ®Google Scholar
• NuttDMiddletonHFranklinMThe neuroendocrine effects of oral imipraminePsychoneuroendocrinology198712367753432499
   PubMed Web of Science ®Google Scholar
• OtaniKYasuiNKanekoSTrazodone treatment increases plasma prolactin concentrations in depressed patientsInt Clin Psychopharmacol199510115177673654
   PubMed Web of Science ®Google Scholar
• PandurangiAKNarasimhachariNBlackardWGRelation of serum molindone levels to serum prolactin levels and antipsychotic responseJ Clin Psychiatry198950379812676994
   PubMed Web of Science ®Google Scholar
• PaneraiAEPetragliaFSacerdotePMainly μ-opiate receptors are involved in LH and PRL secretionEndocrinology1985117109692990867
   PubMed Web of Science ®Google Scholar
• PaolettiAMFlorisSManniasMEvidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopauseJ Clin Endocrinol Metab2001866081211158017
   PubMed Web of Science ®Google Scholar
• PaparrigopoulosTLiappasJTzavellasEAmisulpiride-induced hyperprolactinemia is reversible following discontinuationProg Neuropsychopharmacol Biol Psychiatry20073092616938372
   PubMed Web of Science ®Google Scholar
• PerretGHuguesJNLouchahiMEffect of a short-term oral administration of cimetidine and ranitidine on the basal and thyrotropin-releasing hormone-stimulated serum concentrations of prolactin, thyrotropin and thyroid hormones in healthy volunteers. A double-blind cross-over studyPharmacology19863210183081918
   PubMed Web of Science ®Google Scholar
• PetitAPiednoirDGermainMLDrug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance databaseTherapie2003581596312942857
   PubMed Web of Science ®Google Scholar
• PetrilloMPradaAPorroGBPlasmaprolactin and cimetidineLancet1977276171562
   PubMed Web of Science ®Google Scholar
• PettyRGProlactin and antipsychotic medications: mechanism of actionSchizophr Res199935SupplS677310190227
   PubMed Web of Science ®Google Scholar
• PolleriAMasturzoBMurialdoGDose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humansActa Endocrinol (Copenh)1980937127355667
   PubMedGoogle Scholar
• PollockAMc LarenEHSerum prolactin concentration in patients taking neuroleptic drugsClin Endocrinol (Oxf)199849513169876350
   PubMed Web of Science ®Google Scholar
• PorterRJMcAllister-WilliamsRHYoungAHAcute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteersPsychopharmacology (Berl)1999146194810525755
   PubMed Web of Science ®Google Scholar
• PradalierAVincentDBaerzegarCHyperprolactinemia induced by indoraminTherapie19985350029921044
   PubMed Web of Science ®Google Scholar
• PriceLHCharneyDSDelgadoPLEffects of desipramine and fluvoxamine treatment on prolactin response to tryptophan. Serotoninergic function and mechanism of antidepressant actionArch Gen Psychiatry198946625312500111
   PubMed Web of Science ®Google Scholar
• PriceLHCharneyDSHeningerGREffects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patientsLife Sci198537809184033356
   PubMed Web of Science ®Google Scholar
• PurdonSEJonesBDStipENeuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone or haloperidol. The Canadian Collaborative group for research in schizophreniaArch Gen Psychiatry2000572495810711911
   PubMed Web of Science ®Google Scholar
• RampelloRRaffaeleRNicolettiGNeurobehavioural syndrome induced by H2 receptor blocker withdrawal: possible role of prolactinClin Neuropharmacol19972049549037573
   PubMed Web of Science ®Google Scholar
• ReyniakJVWenofMAubertJMIncidence of hyperprolactinemia during oral contraceptive therapyObstet Gynecol1980558117352067
   PubMed Web of Science ®Google Scholar
• RischSCJanowskyDSSiverLJCorrelated cholinomimetic-stimulated beta-endorphin and prolactin release in humansPeptides19823319226289276
   PubMed Web of Science ®Google Scholar
• RiveraJLLalSEttigiPEffect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groupsClin Endocrinol (Oxf)1976527382954220
   PubMed Web of Science ®Google Scholar
• RobertsonAGBerryRMeltzerHYProlactin stimulating effects of amoxapine and loxapine in psychiatric patientsPsychopharmacology (Berl)198278287926818584
   PubMed Web of Science ®Google Scholar
• RolandiEMagnaniGMilesiGMEffect of a psychoactive drug, trazodone, on prolactin secretion in manNeuropsychobiology1981717197465018
   PubMed Web of Science ®Google Scholar
• RomeoJHDombrowskiRKwackYSHyperprolactinemia and verapamil: prevalence and potential association with hypogonadism in menClin Endocrinol (Oxf)19964557158977754
   PubMed Web of Science ®Google Scholar
• RossiLBonuccelliUMarcacciGynecomastia in epileptics treated with Phenobarbital, phenytoin and fluoresone: two case reportsItal J Neurol Sci19834207106618859
   PubMedGoogle Scholar
• SacharEJGruenPHKarasuTBThioridazine stimulates prolactin secretion in manArch Gen Psychiatry1975328856239662
   PubMed Web of Science ®Google Scholar
• SantalaMSuvanto-LuukkonenEKyllonenAHyperprolactinemia complicating juvenile granulosa cell tumor of the ovaryGynecol Oncol2001823899111531301
   PubMed Web of Science ®Google Scholar
• SchuleCBaghaiTBidlingmaierMEndocrinological effects of mirtazapine in healthy volunteersProg Neuropsychopharmacol Biol Psychiatry20022612536112502011
   PubMed Web of Science ®Google Scholar
• SchliengerJLKapferMTSingerLDifferent effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disordersActa Psychiatr Belg1980805899
   Google Scholar
• SchlosserRGrunderGAnghelescuILong term effects of the substituted benzamide derivative amisulpiride on baseline and stimulated prolactin levelsNeuropsychobiology200246334012207145
   PubMed Web of Science ®Google Scholar
• SeemanPAtypical antipsychotics: mechanism of actionCan J Psychiatry200247273811873706
   PubMed Web of Science ®Google Scholar
• SeppalaTRantaTShrotriyaRCSerum prolactin levels after buspirone in manMed Biol1987656133613693
   PubMedGoogle Scholar
• ShambergerRCRosenbergSASeippCAEffects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcomaCancer Treat Rep198165739466791818
   PubMedGoogle Scholar
• ShinSHObonsawinMCVan VugtDAMorphine can stimulate prolactin release independent of a dopaminergic mechanismCan J Physiol Pharmacol198866138152907416
   PubMed Web of Science ®Google Scholar
• SibiliaVNettiCGuidobonoFCimetidine-induced prolactin release: possible involvement of the GABA-ergic systemNeuroendocrinology198540189922986023
   PubMed Web of Science ®Google Scholar
• SlaterSLLipperSShillingDJElevation of plasmaprolactin by monoamine-oxidase inhibitorsLancet19772275669882
   PubMed Web of Science ®Google Scholar
• SmithSNeuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?J Reprod Med199237737401359137
   PubMed Web of Science ®Google Scholar
• SmithSWheelerMJMurrayRThe effect of antipsychotic–induced hyperprolactinemia on the hypothalamic-pituitary-gonadal axisJ Clin Psychopharmacol2002221091411910254
   PubMed Web of Science ®Google Scholar
• SowersJRSharpBMc CallumRWEffect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, rennin, aldosterone and 18- hydroxycorticosterone secretion in manJ Clin Endocrinol Metab198254869717037817
   PubMed Web of Science ®Google Scholar
• SpigsetOMjorndalTThe effect of fluvoxamine on serum prolactin and serum sodium concentration: relation to platelet 5HT2A receptor statusJ Clin Psychopharmacol19971729279241009
   PubMed Web of Science ®Google Scholar
• SpitzerMSajjadRBenjaminFPattern of development of hyperprolactinemia after initiation of haloperidol therapyObstet Gynecol19989169359572212
   PubMed Web of Science ®Google Scholar
• ŠsagudMPivacNMuck-SelerDEffects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patientsNeuropsychobiology2002451394311979064
   PubMed Web of Science ®Google Scholar
• StannilandCTaylorDTolerability of atypical antipsychoticsDrug Saf20002219521410738844
   PubMed Web of Science ®Google Scholar
• StevensJRKymissisPIBakerAJLElevated prolactin levels in male youths treated with risperidone and quetiapineJ Child Adolesc Psychopharmacol20051589390016379509
   PubMed Web of Science ®Google Scholar
• SteinerJCassarJMashiterKEffect of methyldopa on prolactin and growth hormoneBr Med J19761118681268617
   PubMed Web of Science ®Google Scholar
• StreetJKinonBStaufferVTranPBysmesterFTyeNHerreraJBreierATollefsonGOlanzapine in dementiaOlanzapine (Zyprexa^®): a novel antipsychotic2000PhiladelphiaLippincott Williams and Wilkins Healthcare41627
   Google Scholar
• SulimanAMSmithTPGibneyJFrequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemiaClinical Chemistry2003491504912928232
   PubMed Web of Science ®Google Scholar
• TamagnaEILaneWHerschmanJMEffect of chronic metoclopramide therapy in serum pituitary hormone concentrationHorm Res1979111619574121
   PubMedGoogle Scholar
• TaylorDMAripiprazole: a review of its pharmacology and clinical useInt J Clin Pract200357495412587943
   PubMed Web of Science ®Google Scholar
• TogoTIsekiEShojiMProlactin levels in schizophrenic patients receiving perospirone in comparison to risperidoneJ Pharmacol Sci2003912596212686750
   PubMed Web of Science ®Google Scholar
• TollefsonGDBeasleyCMJrTranPVOlanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAm J Psychiatry1997154457659090331
   PubMed Web of Science ®Google Scholar
• TollinSRUse of dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disordersJ Endocrinol Invest2000237657011194712
   PubMed Web of Science ®Google Scholar
• TranPVHamiltonSHKuntzAJDouble blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disordersJ Clin Pharmacol19971740718
   Google Scholar
• TurronePKapurSSeemanMVElevation of prolactin levels by atypical antipsychoticsAm J Psychiatry2002159133511772702
   PubMed Web of Science ®Google Scholar
• UrbanRJVeldhuisJDA selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal womenAm J Obstet Gynecol19911641 Pt 1147521986602
   PubMed Web of Science ®Google Scholar
• Van VugtDAMeitesJInfluence of endogenous opiates on anterior pituitary functionFed Proc198039253386247213
   PubMedGoogle Scholar
• VeldhuisJDBorgesJLDrakeCRDivergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil on TRH and GnRH stimulated anterior pituitary hormoneJ Clin Endocrinol Metab19856014493880562
   PubMed Web of Science ®Google Scholar
• VercelliniPSacerdotePTrepidiLVeralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled studyFertil Steril199462938427926138
   PubMed Web of Science ®Google Scholar
• Von BardelebenUBenkertOHolsboerFClinical and neuroendocrine effects of zotepine-a new neuroleptic drugPharmacopsychiatry19872028342883678
   PubMed Web of Science ®Google Scholar
• WahlROstroffRReversal of symptomatic hyperprolactinemia by aripiprazoleAm J Psychiatry20051621542316055781
   PubMed Web of Science ®Google Scholar
• WetzelHWiesnerJHiemkeCAcute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteersJ Psychiatr Res199428461737897617
   PubMed Web of Science ®Google Scholar
• WieckAHaddadPMHyperprolactinemia caused by antipsychotic drugsBMJ2002324250211823343
   PubMed Web of Science ®Google Scholar
• WieckAHaddadPMAntipsychotic-induced hyperprolactinemia in women: pathophysiology, severity and consequencesBr J Psychiatry200318219920412611781
   PubMed Web of Science ®Google Scholar
• ZemishlanyZMcQueeneyRGabrielSMNeuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjectsNeuropsychobiology19902312482098668
   PubMed Web of Science ®Google Scholar